37 related articles for article (PubMed ID: 23473612)
21. KRAS testing of patients with metastatic colorectal cancer in a community-based oncology setting: a retrospective database analysis.
Carter GC; Landsman-Blumberg PB; Johnson BH; Juneau P; Nicol SJ; Li L; Shankaran V
J Exp Clin Cancer Res; 2015 Mar; 34(1):29. PubMed ID: 25888436
[TBL] [Abstract][Full Text] [Related]
22. KRAS early testing: consensus initiative and cost-effectiveness evaluation for metastatic colorectal patients in an Italian setting.
Barone C; Pinto C; Normanno N; Capussotti L; Cognetti F; Falcone A; Mantovani L
PLoS One; 2014; 9(1):e85897. PubMed ID: 24465771
[TBL] [Abstract][Full Text] [Related]
23. RAS mutation testing in patients with metastatic colorectal cancer in French clinical practice: A status report in 2014.
Lièvre A; Merlin JL; Sabourin JC; Artru P; Tong S; Libert L; Audhuy F; Gicquel C; Moureau-Zabotto L; Ossendza RA; Laurent-Puig P; Ducreux M
Dig Liver Dis; 2018 May; 50(5):507-512. PubMed ID: 29396127
[TBL] [Abstract][Full Text] [Related]
24. [Observational study on conditions for access to the analysis of KRAS mutation in patients with metastatic colorectal cancer receiving panitumumab treatment].
Bibeau F; Louvet C; Afchain P; Mitry E; Artru P; André T
Bull Cancer; 2012; 99(7-8):743-51. PubMed ID: 22735045
[TBL] [Abstract][Full Text] [Related]
25. Concordant analysis of KRAS status in primary colon carcinoma and matched metastasis.
Mariani P; Lae M; Degeorges A; Cacheux W; Lappartient E; Margogne A; Pierga JY; Girre V; Mignot L; Falcou MC; Salmon RJ; Delattre O; De Cremoux P
Anticancer Res; 2010 Oct; 30(10):4229-35. PubMed ID: 21036746
[TBL] [Abstract][Full Text] [Related]
26. The LCS6 polymorphism in the binding site of let-7 microRNA to the KRAS 3'-untranslated region: its role in the efficacy of anti-EGFR-based therapy in metastatic colorectal cancer patients.
Sebio A; Paré L; Páez D; Salazar J; González A; Sala N; del Río E; Martín-Richard M; Tobeña M; Barnadas A; Baiget M
Pharmacogenet Genomics; 2013 Mar; 23(3):142-7. PubMed ID: 23324806
[TBL] [Abstract][Full Text] [Related]
27. EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.
Schmid K; Oehl N; Wrba F; Pirker R; Pirker C; Filipits M
Clin Cancer Res; 2009 Jul; 15(14):4554-60. PubMed ID: 19584155
[TBL] [Abstract][Full Text] [Related]
28. The KRAS mutation detection within the initial management of patients with metastatic colorectal cancer: a status report in France in 2011.
Lièvre A; Artru P; Guiu M; Laurent-Puig P; Merlin JL; Sabourin JC; Viguier J; Bastie A; Seronde A; Ducreux M
Eur J Cancer; 2013 Jun; 49(9):2126-33. PubMed ID: 23473612
[TBL] [Abstract][Full Text] [Related]
29. Personalized cancer treatment and the myth of KRAS wild-type colon tumors.
Parsons BL; Myers MB
Discov Med; 2013 Apr; 15(83):259-67. PubMed ID: 23636143
[TBL] [Abstract][Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
